Literature DB >> 21112083

Cholera's western front.

Jason B Harris1, Regina C Larocque, Richelle C Charles, Ramendra N Mazumder, Azharul I Khan, Pradip K Bardhan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21112083      PMCID： PMC4815911          DOI： 10.1016/S0140-6736(10)62172-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh.

Authors:  E T Ryan; U Dhar; W A Khan; M A Salam; A S Faruque; G J Fuchs; S B Calderwood; M L Bennish
Journal:  Am J Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.345

2.  Cholera vaccines: WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-03-26

3.  Getting serious about cholera.

Authors:  David A Sack; R Bradley Sack; Claire-Lise Chaignat
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

4.  Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.

Authors:  Mohammad Ali; Michael Emch; Lorenz von Seidlein; Mohammad Yunus; David A Sack; Malla Rao; Jan Holmgren; John D Clemens
Journal:  Lancet       Date:  2005 Jul 2-8       Impact factor: 79.321

5.  Single-dose azithromycin for the treatment of cholera in adults.

Authors:  Debasish Saha; Mohammad M Karim; Wasif A Khan; Sabeena Ahmed; Mohammed A Salam; Michael L Bennish
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

6.  Update: cholera outbreak --- Haiti, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-11-19       Impact factor: 17.586

7.  Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal.

Authors:  M Shahadat Hossain; M A Salam; G H Rabbani; I Kabir; R Biswas; D Mahalanabis
Journal:  J Health Popul Nutr       Date:  2002-03       Impact factor: 2.000

8.  Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis.

Authors:  Marc Jeuland; Joseph Cook; Christine Poulos; John Clemens; Dale Whittington
Journal:  Value Health       Date:  2009-09       Impact factor: 5.725

9.  Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial.

Authors:  G H Rabbani; M R Islam; T Butler; M Shahrier; K Alam
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191
  9 in total
  24 in total

1.  Reinforcing cholera intervention through prediction-aided prevention.

Authors:  Ali S Akanda; Antarpreet S Jutla; David M Gute; Timothy Evans; Shafiqul Islam
Journal:  Bull World Health Organ       Date:  2012-01-20       Impact factor: 9.408

Review 2.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

3.  Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.

Authors:  Mohammad Murshid Alam; M Asrafuzzaman Riyadh; Kaniz Fatema; Mohammad Arif Rahman; Nayeema Akhtar; Tanvir Ahmed; Mohiul Islam Chowdhury; Fahima Chowdhury; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

Review 4.  Vaccines in the time of cholera.

Authors:  John D Clemens
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-11       Impact factor: 11.205

5.  Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Authors:  Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

Review 6.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

7.  Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections.

Authors:  Andrea Rinaldo; Enrico Bertuzzo; Lorenzo Mari; Lorenzo Righetto; Melanie Blokesch; Marino Gatto; Renato Casagrandi; Megan Murray; Silvan M Vesenbeckh; Ignacio Rodriguez-Iturbe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-13       Impact factor: 11.205

8.  Natural selection in a bangladeshi population from the cholera-endemic ganges river delta.

Authors:  Elinor K Karlsson; Jason B Harris; Shervin Tabrizi; Atiqur Rahman; Ilya Shlyakhter; Nick Patterson; Colm O'Dushlaine; Stephen F Schaffner; Sameer Gupta; Fahima Chowdhury; Alaullah Sheikh; Ok Sarah Shin; Crystal Ellis; Christine E Becker; Lynda M Stuart; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri; Pardis C Sabeti; Regina C Larocque
Journal:  Sci Transl Med       Date:  2013-07-03       Impact factor: 17.956

9.  Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.

Authors:  Sweta M Patel; Mohammad Arif Rahman; M Mohasin; M Asrafuzzaman Riyadh; Daniel T Leung; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful I Khan; Ana A Weil; Amena Aktar; Mohammad Nazim; Regina C LaRocque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Clin Vaccine Immunol       Date:  2012-04-18

Review 10.  Immune responses to cholera in children.

Authors:  Daniel T Leung; Fahima Chowdhury; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Expert Rev Anti Infect Ther       Date:  2012-04       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.